A Global, Multicenter, Randomized, Placebo-Controlled Phase 3 Trial to Compare the Efficacy and Safety of Fruquintinib Plus Best Supportive Care to Placebo Plus Best Supportive Care in Patients with Refractory Metastatic Colorectal Cancer

Project: Research

Project Details

Effective start/end date14/05/2113/05/26


  • phase 3 study
  • colorectal cancer
  • treatment safety
  • treatment efficacy